as on November 15, 2025 at 2:29 am IST
Day's Low
6.36%
Downside
52 Week's Low
52 Week's High
65.33%
Downside
-1.84%
Upside
Check Centessa Pharmaceuticals-adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.6B
EPS (TTM)
-1.3825
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-213.5M
Revenue (TTM)
15.0M
Profit Margin
0.00%
Return On Equity TTM
-60.62%
Compare market cap, revenue, PE, and other key metrics of Centessa Pharmaceuticals-adr with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.6B | NA | NA | 0.00% | |
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% | |
| BUY | $71.6B | 22.7% | 16.34 | 32.13% |
The Centessa Pharmaceuticals-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Centessa Pharmaceuticals-adr investment value today
Current value as on today
₹1,63,352
Returns
₹63,352
(+63.35%)
Returns from Centessa Pharmaceuticals-adr Stock
₹58,229 (+58.23%)
Dollar Returns*
₹5,123 (+5.12%)
Based on 11 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Centessa Pharmaceuticals-adr. Average target price of $33.92
Get share price movements and forecasts by analysts on Centessa Pharmaceuticals-adr.
What analysts predicted
18.37%UPSIDE
Target Price
$33.92
Current Price
$27.69
Analyzed by
11 Analysts
Target
$33.92
Centessa Pharmaceuticals-adr target price $33.92, a slight upside of 18.37% compared to current price of $27.69. According to 11 analysts rating.
Search interest for Centessa Pharmaceuticals-adr Stock has increased by 35% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:35% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 11 November
Wed, 02:30 AM
-Centessa Pharmaceuticals announces an underwritten public offering of American Depositary Shares, with a potential 30-day option for underwriters.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, CNTA has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 7 days, CNTA stock has moved up by 24.8%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 20.7%
| Organisation | Centessa Pharmaceuticals-adr |
| Headquarters | 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT |
| Industry | Healthcare |
| CEO | Dr. Saurabh Saha M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Iqbal J. Hussain L.L.B. | General Counsel, Chief Compliance Officer & Corporate Secretary |
Mr. Raphael Deferiere CPA | Chief Accounting Officer & Principal Accounting Officer |
Ms. Karen M. Anderson | Chief People Officer |
Dr. Gregory M. Weinhoff M.B.A., M.D. | Chief Business Officer |
Ms. Charlene Stoudt | Senior Vice President of Clinical Development Operations |
Mr. John J. Crowley CPA | CFO & Principal Financial Officer |
Ms. Tia L. Bush | Chief Technology & Quality Officer |
Ms. Kristen K. Sheppard Esq., J.D. | Senior Vice President of Investor Relations & Corporate Communications |
Dr. Mario Alberto Accardi Ph.D. | President of the Orexin Program |
Dr. Saurabh Saha M.D., Ph.D. | CEO & Director |
Centessa Pharmaceuticals-adr share price today is $27.69 as on at the close of the market. Centessa Pharmaceuticals-adr share today touched a day high of $27.69 and a low of $25.93.
Centessa Pharmaceuticals-adr share touched a 52 week high of $27.18 on and a 52 week low of $9.6 on . Centessa Pharmaceuticals-adr stock price today i.e. is closed at $27.69,which is -1.88% down from its 52 week high and 188.44% up from its 52 week low.
Centessa Pharmaceuticals-adr market capitalisation is $0.00T as on .
Indian investors can start investing in Centessa Pharmaceuticals-adr (CNTA) shares with as little as ₹88.64 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.40 in Centessa Pharmaceuticals-adr stock (as per the Rupee-Dollar exchange rate as on ).
Based on Centessa Pharmaceuticals-adr share’s latest price of $27.69 as on November 15, 2025 at 2:29 am IST, you will get 0.3611 shares of Centessa Pharmaceuticals-adr. Learn more about
fractional shares .